Health Condition 1: O140- Mild to moderate pre-eclampsia Health Condition 2: O140- Mild to moderate pre-eclampsia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient providing written informed consent voluntarily patient of 19-40 yrs American society of anesthesiologist grade 2 patient newly diagnosed to have Pre-eclampsia patient of pre eclampsia on treatment patient with weight 50- 80 kgs height of 150 - 170cm patient with pre eclampsia undergoing elective or emergency lower segment cesarean section in uncomplicated pregnancies under spinal anesthesia patient who develop hypotension following spinal anesthesia
Exclusion criteria
Exclusion criteria: Patients with ASA III or higher Allergic to the study drug Complicated Pregnancies -Multiple pregnancy, preterm LSCS, umbilical cord prolapse, HELLP, Eclampsia, Antepartum hemorrhage Bad obstetric history Inadequate level of spinal anesthesia Fetal growth restriction (estimated fetal weight less than 3rd centile for given gestational age [8]) Pre-existing HTN, Cerebral disease, Raised ICP, Severe PIH GDM, Epilepsy, Cardiac disease, Congestive heart failure resting heart rate less than 60 bpm Fetal anomalies in obstetric scans
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of episodes of hypotension after giving the first dose of phenylephrineTimepoint: Blood pressure , heart rate , saturation will be monitored at an interval of 3 mins | — |
Secondary
| Measure | Time frame |
|---|---|
| Increase in MAP following the first dose of phenylephrineTimepoint: MAP measured immediately after administration of phenylephrine and and after 3 minutes of admisnistration | — |
Countries
India
Contacts
Bangalore medical college and research institute